BERTANI, Nicoletta
 Distribuzione geografica
Continente #
NA - Nord America 558
EU - Europa 474
AS - Asia 228
Totale 1.260
Nazione #
US - Stati Uniti d'America 554
CN - Cina 189
IE - Irlanda 151
SE - Svezia 91
FI - Finlandia 76
DE - Germania 43
IT - Italia 41
TR - Turchia 36
UA - Ucraina 33
BE - Belgio 25
GB - Regno Unito 8
AT - Austria 4
CA - Canada 4
JP - Giappone 2
ES - Italia 1
IR - Iran 1
NL - Olanda 1
Totale 1.260
Città #
Chandler 185
Dublin 151
Jacksonville 57
Dearborn 54
Ann Arbor 46
Beijing 38
Izmir 36
Nanjing 34
Brussels 25
Princeton 22
Wilmington 22
Jinan 18
San Mateo 17
Parma 16
Shenyang 13
Kunming 9
Nanchang 9
Zhengzhou 8
Hebei 7
Tianjin 7
Boardman 6
Bremen 6
Changsha 6
Jiaxing 6
Hangzhou 5
Hefei 5
Cornaredo 4
Düsseldorf 4
Helsinki 4
Taiyuan 4
Toronto 4
Vienna 4
Falls Church 3
Fuzhou 3
Guangzhou 3
Norwalk 3
Washington 3
Auburn Hills 2
Cagliari 2
Fremont 2
Haikou 2
Houston 2
Mountain View 2
Solignano 2
Taizhou 2
Tokyo 2
Woodbridge 2
Ashburn 1
Assergi 1
Bethesda 1
Borås 1
Budrio 1
Cambridge 1
Dallas 1
Des Moines 1
Grafing 1
Lanzhou 1
Milan 1
Ningbo 1
Orland Park 1
Philadelphia 1
Redwood City 1
Rio Saliceto 1
San Lazzaro di Savena 1
Segrate 1
Shanghai 1
Stockholm 1
Xian 1
Zanjan 1
Totale 889
Nome #
Periaortite cronica e vasculite dei piccoli vasi: studio morfologico-clinico 92
Prognostic modeling of oral cancer by gene profiles and clinicopathological co-variables 84
Drug resistance in higly aggressive acute leukemias is controlled by de novo espressed NG2 proteoglycan acting via modulation of selected transporters 80
Proteoglycans in metastasis formation and anti-neoplastic therapeutic approaches 78
Prognostic role of XTP1/DEPDC1B and SDP35/DEPDC1A in high grade soft-tissue sarcomas 72
Chronic cardiotoxicity of anticancer anthracyclines in the rat: role of secondary metabolites and reduced toxicity by a novel anthracycline with impaired metabolite formation and reactivity. 68
The NeoMark Project interim results: integration of heterogeneous data for prediction of oral squamous cell cancer (OSCC) recurrence. 68
Evidences for myocyte apoptosis in the heart 67
Myocardial remodeling in patients with severe aortic stenosis is associated with increased oxidative stress. 60
Integration of clinical, histopathological, radiological and biomolecular data for prediction of oral squamous cell cancer (OSCC) recurrence: the NeoMark Project’s first report. 57
Neurogenic potential of human mesenchymal stem cells revised by time-lapse vide-microscopy and wide scale gene expression profiling 54
Proteoglycans as Potential Markers of the Biological Behaviour of Head and Neck Carcinomas: Interim Results of a Multicenter Italian Project. 53
Proteoglycans as potential markers of the biological behaviour of head and neck carcinomas: Interim Results of a Multicenter Italian Project. 52
Integration of clinical, histopathological, radiological and biomolecular data for prediction of oral squamous cell cancer (OSCC) recurrence: the NeoMark project’s interim results. 48
“Evidences for Myocyte Apoptosis in the Heart” 48
Integration of clinical, histopathological, radiological and biomolecular data for prediction of oral cancer recurrence: the NeoMark Project’s first report. 48
Evaluation of immunohistochemical and biomolecular parameters as markers of the biological behaviour of head and neck carcinomas: preliminary results of a multicenter Italian Project. 47
Drug resistance in highly aggressive acute leukemias is controlled by de novo, expressed NG2 proteoglycan acting via modulation of selected transporters 43
“Chronic cardiotoxicity of anticancer anthracyclines in the rat: role of secondary metabolites and reduced toxicity by a novel anthracycline with impaired metabolite formation and reactivity” 42
Risk stratification and prediction of locoregional recurrence in patients affected by oral squamous cell carcinoma (OSCC): the NeoMark project results. 41
Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors 41
Tumor cell NG2 proteoglycan controls cancer progression through its interaction with host Collagen type VI 27
Totale 1.270
Categoria #
all - tutte 2.851
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.851


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201958 0 0 0 1 3 4 0 1 5 3 40 1
2019/2020296 49 31 10 4 14 46 44 12 26 42 2 16
2020/2021118 3 11 8 4 19 1 8 4 43 2 15 0
2021/2022105 2 2 6 5 3 2 8 20 5 12 12 28
2022/2023532 37 71 23 58 41 62 3 35 172 2 20 8
2023/202441 21 15 5 0 0 0 0 0 0 0 0 0
Totale 1.270